Order Dormicum online
Dormicum is a somnolent drug. The Dormicum active substance is midazolam. Dormicum has a very fast sedative and soporific effect. It also has anxiolytic, anticonvulsant, myorelaxing effect. A short anterograde amnesia is after the injection (the patient does not remember the events that took place in the period of the most intense action of the active substance). Application: insomnia, premedication before the diagnostic and surgical procedures, prolonged sedation in intensive treatment, initial narcosis with inhalation anesthesia or as somnolent in combined anaesthesia, ataralgesia in children.
Dormicum is a soporific drug of the benzodiazepine derivatives group, has anxiolytic, sedative, central muscle relaxing and anticonvulsant effect. The drug has a low latency period (cause sleep within 20 minutes after taking inside); has a weak effect on the structure of sleep.
Midazolam should not be combined with drugs, providing a depressing effect on the central nervous system. Dormicum enhances the action of anesthetic and analgesic drugs.
The drug is contraindicated in pregnancy.
Side effects: CNS: weakness, drowsiness, fatigue. In patients awakened in the early hours after midazolam administration, amnesia may occur. In long time administration the drug dependency may be developed. Allergic reactions: skin eruption, urticaria, angioneurotic edema.
Indications for the drug using: sleep disorders; premedication before surgery and diagnostic procedures; the introduction of anaesthesia and its maintenance.
Contraindications: myasthenia, pregnancy, increased sensitivity to benzodiazepine.
You should take the remedy according the doctor instructions exactly.
Blood transfusions: Is there a limit?
When do you need a blood transfusion? Is there a maximum number of blood transfusions a person can have? Find out in this article.Sat, 20 Jan 2018, 15:00
Two drinks per day may be too much for men
A new study shows that men who start drinking as teenagers have a higher risk of liver disease. Dosage counts and current guidelines may be too lax.Mon, 22 Jan 2018, 10:00